Search

Your search keyword '"Viral antibodies -- Health aspects -- Analysis"' showing total 82 results
Start Over Descriptor "Viral antibodies -- Health aspects -- Analysis"
82 results on '"Viral antibodies -- Health aspects -- Analysis"'

1. Evidence of Zika Virus Reinfection by Genome Diversity and Antibody Response Analysis, Brazil

Author

Castilho, Marcia da Costa, de Filippis, Ana Maria Bispo, Machado, Lais Ceschini, de Lima Calvanti, Thaise Yasmine Vasconcelos, Lima, Morganna Costa, Fonseca, Vagner, Giovanetti, Marta, Docena, Cassia, Neto, Armando Menezes, Botto-Menezes, Camila Helena Aguiar, Kara, Edna Oliveira, de La Barrera, Rafael, Modjarrad, Kayvon, Giozza, Silvana Pereira, Pereira, Gerson Fernando, Alcantara, Luiz Carlos Junior, Broutet, Nathalie Jeanne Nicole, Calvet, Guilherme Amaral, Wallau, Gabriel Luz, and Franca, Rafael Freitas Oliveira

Subjects
Genomics -- Analysis -- Health aspects, Viral antibodies -- Health aspects -- Analysis, Genomes -- Analysis -- Health aspects, Phylogeny -- Health aspects -- Analysis, Antibodies -- Health aspects -- Analysis, Health, World Health Organization
Abstract

Zika virus (ZIKV) is an arthropodborne virus belonging to the Flaviviridae family. Virions are enveloped for a single-stranded positive-sense RNA genome of [approximately equal to]10.8-kb (1). ZIKV is transmitted through [...]

Published
2024
Full Text
View/download PDF

2. New Loiasis Findings Reported from University of Montpellier (Evaluation of a Novel Biplex Rapid Diagnostic Test for Antibody Responses To loa Loa and onchocerca Volvulus Infections)

Subjects
Medical tests -- Analysis -- Health aspects, Viral antibodies -- Health aspects -- Analysis, Parasitic diseases -- Analysis -- Health aspects, Antibodies -- Health aspects -- Analysis, Physical fitness -- Analysis -- Health aspects, Health, Public Library of Science
Abstract

2024 NOV 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Fresh data on Parasitic Diseases and Conditions - Loiasis are presented in [...]

Published
2024

3. Evidence of 'Silent' Hepatitis B Virus Infection in Psoriasis, Vitiligo, and Pityriasis Rosea Cases: A Pilot Study

Author

Supekar, Ruchi, Roy, Subrata, De, Abhishek, and Biswas, Subhajit

Subjects
Psoriasis -- Development and progression, Medical research -- Analysis -- Health aspects, Genes -- Analysis -- Health aspects, Immune response -- Health aspects -- Analysis, Viral antibodies -- Health aspects -- Analysis, Skin -- Analysis -- Health aspects, Viral proteins -- Health aspects -- Analysis, Pityriasis rosea -- Development and progression, Medicine, Experimental -- Analysis -- Health aspects, Interferon gamma -- Health aspects -- Analysis, Ethylenediaminetetraacetic acid -- Analysis -- Health aspects, Biological response modifiers -- Analysis -- Health aspects, Hepatitis B -- Development and progression, Hepatitis B virus -- Development and progression, Antibodies -- Health aspects -- Analysis, Health
Abstract

Background: Psoriasis (PS), vitiligo (VT), and Pityriasis rosea (PR) are chronic skin diseases often occurring as a consequence of exaggerated immune responses. These skin manifestations can be triggered as a result of the molecular mimicry between viral protein (s) and host protein (s), which could generate auto-antibodies. In addition, it can be hypothesised that skin diseases are manifestations of the reduced immunity that is observed in chronic hepatitis B virus (HBV)-infected individuals. Aims and Objective: To investigate the presence of HBV in PS, VT, and PR cases and Human Herpes Virus (HHV) 6 and 7 in PR cases. Materials and Methods: DNA extracted from healthy controls (n = 20), PS (n = 10), VT (n = 11), and PR (n = 12) were subjected to HBV-S gene-specific polymerase chain reactions (PCRs) and HHV 6-UL57 and HHV7-UL10 gene-specific PCRs. PCR products of positive samples (HBV and HHV 6 and 7 DNA) of expected length were bi-directionally sequenced using overlapping primers. Sequence identification was performed by NCBI BLAST and analysed by multiple sequence alignment. HBV DNA copy number was determined through quantitative real-time PCR. The blood samples were also tested for HBV serological markers and Interferon gamma (IFN-γ) by enzyme immunoassays. Results: The PCR data and Immunoassay study revealed that seven out of 12 PR, six out of 10 PS, and six out of 11 VT cases had signs of HBV infection. HHV 6 DNA was detected in four, whereas HHV 7 DNA was found in two of the 12 PR blood samples. PR6 presented the evidence of both HHV 6 and 7 co-infections. Conclusion: Observing the correlation of HBV with skin diseases, albeit at the pilot level, a larger study is warranted to identify HBV infection in skin disease patients. The evidence of HHV 6 and HHV 7 DNA in PR cases supports the HHV infection linkage with PR. Keywords: Co-infection, Pityriasis rosea, psoriasis, vitiligo, KEY MESSAGES: Underlying viral infections may be linked to chronic skin disease manifestations. Evidence of high frequency of HBV infection in PS, VT, and PR cases and the presence of HHV 6 and/or 7 infections in PR draw a diagnostic perspective for screening these subjects for these viruses as well., Author(s): Ruchi Supekar [1,2]; Subrata Roy [2]; Abhishek De [3]; Subhajit Biswas (corresponding author) [1,2] Introduction Psoriasis (PS), vitiligo (VT), and Pityriasis rosea (PR) are chronic skin diseases that often [...]

Published
2024
Full Text
View/download PDF

4. LAIR-1 agonism as a therapy for acute myeloid leukemia

Author

Lovewell, Rustin R., Hong, Junshik, Kundu, Subhadip, Fielder, Carly M., Hu, Qianni, Kim, Kwang Woon, Ramsey, Haley E., Gorska, Agnieszka E., Fuller, Londa S., Tian, Linjie, Kothari, Priyanka, Paucarmayta, Ana, Mason, Emily F., Meza, Ingrid, Manzanarez, Yanira, Bosiacki, Jason, Maloveste, Karla, Mitchell, Ngan, Barbu, Emilia A., Morawski, Aaron, Maloveste, Sebastien, Cusumano, Zac, Patel, Shashank J., Savona, Michael R., Langermann, Solomon, Myint, Han, Flies, Dallas B., and Kim, Tae Kon

Subjects
STEMCELL Technologies Inc., Viral antibodies -- Health aspects -- Analysis, Collagen -- Analysis -- Health aspects, B cells -- Analysis -- Health aspects, Cancer -- Care and treatment, Diagnostic reagents industry -- Analysis -- Health aspects, Hematopoietic stem cells -- Health aspects -- Analysis, Apoptosis -- Analysis -- Health aspects, Antibodies -- Health aspects -- Analysis, Health care industry, Vanderbilt University. Medical Center
Abstract

Effective eradication of leukemic stem cells (LSCs) remains the greatest challenge in treating acute myeloid leukemia (AML). The immune receptor LAIR-1 has been shown to regulate LSC survival; however, the therapeutic potential of this pathway remains unexplored. We developed a therapeutic LAIR-1 agonist antibody, NC525, that induced cell death of LSCs, but not healthy hematopoietic stem cells in vitro, and killed LSCs and AML blasts in both cell- and patient-derived xenograft models. We showed that LAIR-1 agonism drives a unique apoptotic signaling program in leukemic cells that was enhanced in the presence of collagen. NC525 also significantly improved the activity of azacitidine and venetodaxto establish LAIR-1 targeting as a therapeutic strategy for AML that may synergize with standard-of-care therapies., Introduction Acute leukemias are characterized by the uncontrolled production of malignant hematopoietic progenitors. Acute myeloid leukemia (AML) is the most common adult acute leukemia (1). While extensive research has led [...]

Published
2023
Full Text
View/download PDF

5. Tumor-derived biomarkers predict efficacy of B7H3 antibody-drug conjugate treatment in metastatic prostate cancer models

Author

Agarwal, Supreet, Fang, Lei, McGowen, Kerry, Yin, JuanJuan, Bowman, Joel, Ku, Anson T., Alilin, Aian Neil, Corey, Eva, Roudier, Martine P., True, Lawrence D., Dumpit, Ruth, Coleman, Ilsa, Lee, John K., Nelson, Peter S., Capaldo, Brian J., Mariani, Aida, Hoover, Clare, Senatorov, Ilya S., Beshiri, Michael, Sowalsky, Adam G., Hurt, Elaine M., and Kelly, Kathleen

Subjects
United States. National Cancer Institute -- Analysis, AstraZeneca PLC, Biopharmaceutics -- Health aspects -- Analysis, Tumor proteins -- Drug therapy, Prostate cancer -- Drug therapy, Antineoplastic agents -- Health aspects -- Analysis, Metastasis -- Drug therapy, Viral antibodies -- Health aspects -- Analysis, Antigens -- Analysis -- Health aspects, Antibodies -- Health aspects -- Analysis, Biological markers -- Health aspects -- Analysis, Pharmaceutical industry -- Health aspects -- Analysis, Antimitotic agents -- Health aspects -- Analysis, Health care industry
Abstract

Antibody-drug conjugates (ADCs) are a promising targeted cancer therapy; however, patient selection based solely on target antigen expression without consideration for cytotoxic payload vulnerabilities has plateaued clinical benefits. Biomarkers to capture patients who might benefit from specific ADCs have not been systematically determined for any cancer. We present a comprehensive therapeutic and biomarker analysis of a B7H3-ADC with pyrrolobenzodiazepine(PBD) payload in 26 treatment- resistant, metastatic prostate cancer (mPC) models. B7H3 is a tumor-specific surface protein widely expressed in mPC, and PBD is a DNA cross-linking agent. B7H3 expression was necessary but not sufficient for B7H3-PBD-ADC responsiveness. RB1 deficiency and/or replication stress, characteristics of poor prognosis, and conferred sensitivity were associated with complete tumor regression in both neuroendocrine (NEPC) and androgen receptor positive (ARPC) prostate cancer models, even with low B7H3 levels. Non-ARPC models, which are currently lacking efficacious treatment, demonstrated the highest replication stress and were most sensitive to treatment. In RB1 WT ARPC tumors, SLFN11 expression or select DNA repair mutations in SLFN11 nonexpressors governed response. Importantly, WT TP53 predicted nonresponsiveness (7 of 8 models). Overall, biomarker-focused selection of models led to high efficacy of in vivo treatment. These data enable a paradigm shift to biomarker-driven trial designs for maximizing clinical benefit of ADC therapies., Introduction Metastatic prostate cancer (mPC) remains a lethal disease accounting for more than 30,000 deaths annually in the United States (1). The use of androgen deprivation therapy (ADT) and androgen [...]

Published
2023
Full Text
View/download PDF

6. Studies in the Area of COVID-19 Reported from Toyama Institute of Health (Neutralizing Antibody Levels and Epidemiological Characteristics of Patients With Breakthrough Covid-19 Infection In Toyama, Japan)

Subjects
Analysis, Health aspects, Coronaviruses -- Health aspects -- Analysis, Medical research -- Analysis -- Health aspects, Infection -- Health aspects -- Analysis, Antibodies -- Health aspects -- Analysis, Epidemiology -- Analysis -- Health aspects, COVID-19 -- Health aspects -- Analysis, Medicine, Experimental -- Analysis -- Health aspects, Viral antibodies -- Health aspects -- Analysis
Abstract

2024 NOV 24 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Investigators discuss new findings in Coronavirus - COVID-19. According to [...]

Published
2024

7. Causal Effects of Herpesvirus-Associated Antibodies on Autoimmune neuroinflammatory diseases: Mendelian Randomization Study

Subjects
Medical research -- Analysis -- Health aspects, Medicine, Experimental -- Analysis -- Health aspects, Guillain-Barre syndrome -- Health aspects -- Analysis, Nervous system diseases -- Analysis -- Health aspects, Multiple sclerosis -- Health aspects -- Analysis, Viral antibodies -- Health aspects -- Analysis, Antibodies -- Health aspects -- Analysis
Abstract

2024 NOV 22 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- According to news reporting based on a preprint abstract, our journalists obtained the [...]

Published
2024

8. Age-specific dynamics of neutralizing antibodies, cytokines, and chemokines in response to La Crosse virus infection in mice (Updated October 4, 2024)

Subjects
Cytokines -- Health aspects -- Analysis, Viral antibodies -- Health aspects -- Analysis, Infection -- Health aspects -- Analysis, Antibodies -- Health aspects -- Analysis, Virus diseases -- Health aspects -- Analysis, Health
Abstract

2024 OCT 25 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- According to news reporting based on a preprint abstract, our journalists obtained the [...]

Published
2024

9. Joint Impacts of Nutrition and Socioeconomic Status on SARS-CoV-2 Antibody Titer in a Prospective Birth Cohort in Brazil

Subjects
Vaccination -- Health aspects -- Analysis, Viral antibodies -- Health aspects -- Analysis, Vaccines -- Health aspects -- Analysis, Antibodies -- Health aspects -- Analysis, Social classes -- Analysis -- Health aspects, Business, Health, Health care industry
Abstract

2024 SEP 15 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- According to news reporting based on a preprint abstract, our [...]

Published
2024

10. Evaluation of SARS-CoV-2 antibody response between paired fingerprick (hemaPEN) and venepuncture collected samples in children and adults

Subjects
Viral antibodies -- Health aspects -- Analysis, Severe acute respiratory syndrome -- Analysis -- Health aspects, Antibodies -- Health aspects -- Analysis, Coronaviruses -- Health aspects -- Analysis
Abstract

2024 AUG 18 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- According to news reporting based on a preprint abstract, our [...]

Published
2024

11. New Findings from Department of Research and Development in the Area of COVID-19 Described (Differences In Sars-cov-2 Antibodies Depending On Age, Blood Group, and Sex In a Swedish Blood Donor Cohort)

Subjects
ElecSys Inc., Viral antibodies -- Health aspects -- Analysis, Electronic components industry -- Health aspects -- Analysis, Antibodies -- Health aspects -- Analysis, Industrial research -- Sweden -- United States, Blood proteins -- Health aspects -- Analysis, Coronaviruses -- Health aspects -- Analysis, Blood donors -- Analysis -- Health aspects, Research and development, Business, Health, Health care industry
Abstract

2024 JUL 21 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- A new study on Coronavirus - COVID-19 is now available. [...]

Published
2024

12. Anti-Nucleocapsid and Anti-Spike Antibody Trajectories in People with Post-Covid Condition versus Acute-Only Infections: Results from the Virus Watch Prospective Cohort Study

Subjects
Viral antibodies -- Health aspects -- Analysis, Infection -- Health aspects -- Analysis, Antibodies -- Health aspects -- Analysis, Business, Health, Health care industry
Abstract

2024 JUL 7 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- According to news reporting based on a preprint abstract, our [...]

Published
2024

13. Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1 (Updated June 12, 2024)

Subjects
Viral antibodies -- Health aspects -- Analysis, B cells -- Analysis -- Health aspects, Vaccines -- Health aspects -- Analysis, Antibodies -- Health aspects -- Analysis, Business, Health, Health care industry
Abstract

2024 JUN 30 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- According to news reporting based on a preprint abstract, our [...]

Published
2024

14. Test For The Determination Of Antibodies To Hiv Types 1 And 2 (test Cassette), Nk 024:2023 48446 - Hiv-1/hiv-2, Ivd Antigens/antibodies (in Vitro Diagnostics); Test For Detection Of Viral Hepatitis B, No. 25 (test Cassette), Code Nk 024:2023: 48321 Hepati

Subjects
HIV (Viruses) -- Analysis -- Health aspects, Diagnostic reagents -- Analysis -- Health aspects, HIV testing -- Analysis -- Health aspects, Viral antibodies -- Health aspects -- Analysis, Hepatitis C virus -- Health aspects -- Analysis, Medical testing products -- Analysis -- Health aspects, Hepatitis B -- Analysis -- Health aspects, Antibodies -- Health aspects -- Analysis, HIV infection -- Analysis -- Health aspects, Business, international
Abstract

Tenders Are Invited For: Test For The Determination Of Antibodies To Hiv 1 And 2 Types (Test Cassette), Nk 024:2023 48446 - Hiv-1/Hiv-2, Ivd Antigens/Antibodies (In Vitro Diagnostics); Test For [...]

Published
2024

15. Tempus Released New Data at AACR Showcasing Ways to Analyze Multimodal Data to Highlight Potential Therapeutic Routes for HER2-Directed Antibody-Drug Conjugates in Several Tumor Types

Subjects
Biopharmaceutics -- Health aspects -- Analysis, Tumors -- Drug therapy, Viral antibodies -- Health aspects -- Analysis, Stomach cancer -- Drug therapy, RNA -- Health aspects -- Analysis, Antibodies -- Health aspects -- Analysis, General interest, News, opinion and commentary
Abstract

CHICAGO: Tempus, a leader in artificial intelligence and precision medicine, will present new data along with Pfizer at the AACR 2024 Annual Meeting. The abstract, titled Analysis of HER2 prevalence [...]

Published
2024

16. Assessment of neutralization susceptibility of Omicron subvariants XBB.1.5 and BQ.1.1 against broad-spectrum neutralizing antibodies through epitopes mapping

Subjects
Antigenic determinants -- Analysis -- Health aspects, Viral antibodies -- Health aspects -- Analysis, Antibodies -- Health aspects -- Analysis, Physical fitness -- Analysis -- Health aspects, Health
Abstract

2023 MAR 25 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting based on a preprint abstract, our journalists obtained [...]

Published
2023

17. Age-specific dynamics of neutralizing antibodies, cytokines, and chemokines in response to La Crosse virus infection in mice

Subjects
Cytokines -- Health aspects -- Analysis, Viral antibodies -- Health aspects -- Analysis, Antibodies -- Health aspects -- Analysis, Virus diseases -- Health aspects -- Analysis, Health
Abstract

2024 MAY 24 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- According to news reporting based on a preprint abstract, our journalists obtained the [...]

Published
2024

18. Antibody responses in Klebsiella pneumoniae bloodstream infection: a cohort study

Subjects
Antigen-antibody reactions -- Analysis -- Health aspects, Medical research -- Analysis -- Health aspects, Medicine, Experimental -- Analysis -- Health aspects, Bacterial pneumonia -- Health aspects -- Analysis, Polysaccharides -- Analysis -- Health aspects, Viral antibodies -- Health aspects -- Analysis, Pneumonia -- Health aspects -- Analysis, Vaccines -- Health aspects -- Analysis, Antibodies -- Health aspects -- Analysis, Health
Abstract

2024 MAY 22 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- According to news reporting based on a preprint abstract, our journalists obtained the following quote [...]

Published
2024

19. Relationship between therapeutic activity and preferential targeting of toxic soluble aggregates by amyloid-beta-directed antibodies

Subjects
Oligomers -- Health aspects -- Analysis, Viral antibodies -- Health aspects -- Analysis, Alzheimer's disease -- Health aspects -- Analysis, Antibodies -- Health aspects -- Analysis, Health
Abstract

2024 MAY 15 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- According to news reporting based on a preprint abstract, our journalists obtained the following quote [...]

Published
2024

20. Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1

Subjects
Viral antibodies -- Health aspects -- Analysis, Vaccines -- Health aspects -- Analysis, Antibodies -- Health aspects -- Analysis, Health
Abstract

2024 MAY 8 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- According to news reporting based on a preprint abstract, our journalists obtained the following quote [...]

Published
2024

22. Data from Keio University Provide New Insights into COVID-19 (The Utility of Smartphone-based Quantitative Analysis of Sars-cov-2-specific Antibody Lateral Flow Assays)

Subjects
Viral antibodies -- Health aspects -- Analysis, Smart phones -- Analysis -- Health aspects, Antibodies -- Health aspects -- Analysis, Coronaviruses -- Health aspects -- Analysis, Smart phone, Business, Health, Health care industry, Keio University
Abstract

2024 MAR 31 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Investigators discuss new findings in Coronavirus - COVID-19. According to [...]

Published
2024

23. Discovery of anti-SARS-CoV-2 S2 protein antibody CV804 with broad-spectrum reactivity with various beta coronaviruses and analysis of its pharmacological properties in vitro and in vivo

Subjects
Antigen-antibody reactions -- Analysis -- Health aspects, Biological products -- Analysis -- Health aspects, Viral antibodies -- Health aspects -- Analysis, Antibodies -- Health aspects -- Analysis, Coronaviruses -- Health aspects -- Analysis, Business, Health, Health care industry
Abstract

2024 MAR 24 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- According to news reporting based on a preprint abstract, our [...]

Published
2024

24. Diagnostic Test Strips (test For Detection Of Hepatitis B Hbsag|hiv Type I And Ii|hepatitis C - 33124131-2 (42652 - Control Material For The Determination Of Antigens|antibodies To Multiple Hemocontact Infections, Ivd (in Vitro Diagnostics); Test Strips F

Subjects
HIV (Viruses) -- Analysis -- Health aspects, Diagnostic reagents -- Analysis -- Health aspects, City councils -- Health aspects -- Analysis, Medical tests -- Analysis -- Health aspects, Viral antibodies -- Health aspects -- Analysis, Antigens -- Analysis -- Health aspects, Infection -- Health aspects -- Analysis, Medical testing products -- Analysis -- Health aspects, Hepatitis B -- Analysis -- Health aspects, Antibodies -- Health aspects -- Analysis, Hepatitis C -- Analysis -- Health aspects, Business, international
Abstract

Tenders are invited for diagnostic test strips (test for detection of hepatitis b hbsag/hiv type i and ii/hepatitis c - 33124131-2 (42652 - control material for the determination of antigens/antibodies [...]

Published
2023

25. 52521 - Extraction|isolation Of Nucleic Acids, Ivd Kit (in Vitro Diagnostics) (reagent Kit For Dna And Rna Extraction From Human Biological Material 96 Tests In The Kit), 50284 - Corona Virus (sars-cov), Nucleic Acid Ivd (in Vitro Diagnostics) , Set, Anal

Subjects
Diagnostic reagents -- Analysis -- Health aspects, DNA -- Analysis -- Health aspects, Diagnostic reagents and test kits -- Analysis -- Health aspects, Testing equipment -- Health aspects -- Analysis, Viral antibodies -- Health aspects -- Analysis, Medical testing products -- Analysis -- Health aspects, Hepatitis B -- Analysis -- Health aspects, Antibodies -- Health aspects -- Analysis, Business, international
Abstract

Tenders are invited for 52521 - extraction/isolation of nucleic acids, ivd kit (in vitro diagnostics) (reagent kit for dna and rna extraction from human biological material 96 tests in the [...]

Published
2023

27. Researchers from Huadong Medical Institute of Biotechniques Report Recent Findings in Thrombocytopenia (Development and Evaluation of Two Double-antibody Sandwich Elisas for Detecting Severe Fever With Thrombocytopenia Syndrome Virus Infection)

Subjects
Medical research -- Analysis -- Health aspects, Medicine, Experimental -- Analysis -- Health aspects, Antiviral agents -- Health aspects -- Analysis, Viral antibodies -- Health aspects -- Analysis, Infection -- Health aspects -- Analysis, Vaccines -- Health aspects -- Analysis, Antibodies -- Health aspects -- Analysis, Physical fitness -- Analysis -- Health aspects, Thrombocytopenia -- Health aspects -- Analysis, Virus diseases -- Health aspects -- Analysis, Health
Abstract

2022 APR 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Hematologic Diseases and Conditions - Thrombocytopenia have been [...]

Published
2022

28. DeepSCM: an efficient convolutional neural network surrogate model for the screening of therapeutic antibody viscosity

Subjects
Molecular dynamics -- Health aspects -- Analysis, Biopharmaceutics -- Health aspects -- Analysis, Viral antibodies -- Health aspects -- Analysis, Neural networks -- Analysis -- Health aspects, Antibodies -- Health aspects -- Analysis, Physical fitness -- Analysis -- Health aspects, Neural network, Health
Abstract

2022 APR 2 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting based on a preprint abstract, our journalists obtained [...]

Published
2022

29. Serum Antibody Fingerprinting for SARS-CoV-2 Variants in Infected and Vaccinated Subjects by Label-Free Microarray Biosensor

Subjects
Vaccination -- Health aspects -- Analysis, Detectors -- Analysis -- Health aspects, Viral antibodies -- Health aspects -- Analysis, Antibodies -- Health aspects -- Analysis, Virus diseases -- Health aspects -- Analysis, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2023 NOV 22 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- According to news reporting based on a preprint abstract, our journalists obtained the following quote [...]

Published
2023

30. Antibody Evasion Properties of SARS-CoV-2 Omicron Sublineages

Subjects
Viral antibodies -- Health aspects -- Analysis, Severe acute respiratory syndrome -- Analysis -- Health aspects, Antibodies -- Health aspects -- Analysis, Coronaviruses -- Health aspects -- Analysis, Physical fitness -- Analysis -- Health aspects, Health
Abstract

2022 FEB 26 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting based on a preprint abstract, our journalists obtained [...]

Published
2022

31. Anti SARS-CoV-2 Antibody Kinetics up to 6 months of follow-up: Result from a Nation-wide Population-based, Age Stratified Sero-Epidemiological Prospective Cohort Study in India

Subjects
Viral antibodies -- Health aspects -- Analysis, Epidemiology -- Analysis -- Health aspects, Antibodies -- Health aspects -- Analysis, Business, Health, Health care industry
Abstract

2023 JUL 9 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- According to news reporting based on a preprint abstract, our [...]

Published
2023

32. Pre-infection neutralizing antibodies, Omicron BA.5 breakthrough infection, and long COVID: a propensity score-matched analysis

Subjects
Coronavirus infections -- Health aspects -- Analysis, Medical research -- Analysis -- Health aspects, Medicine, Experimental -- Analysis -- Health aspects, Viral antibodies -- Health aspects -- Analysis, Infection -- Health aspects -- Analysis, Vaccines -- Health aspects -- Analysis, Antibodies -- Health aspects -- Analysis, Coronaviruses -- Health aspects -- Analysis, Health
Abstract

2023 APR 26 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- According to news reporting based on a preprint abstract, our journalists obtained the following quote [...]

Published
2023

34. Dosing of convalescent plasma and hyperimmune anti-SARS-CoV-2 1 immunoglobulins: a phase I/II dose finding study

Subjects
Vaccination -- Health aspects -- Analysis, Viral antibodies -- Health aspects -- Analysis, Antibodies -- Health aspects -- Analysis, Blood proteins -- Health aspects -- Analysis, Business, Health, Health care industry
Abstract

2023 APR 2 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- According to news reporting based on a preprint abstract, our [...]

Published
2023

36. Neutralizing antibody levels and epidemiological information of patients with breakthrough COVID-19 infection in Toyama, Japan

Subjects
Viral antibodies -- Health aspects -- Analysis, Infection -- Health aspects -- Analysis, Epidemiology -- Analysis -- Health aspects, Antibodies -- Health aspects -- Analysis, Coronaviruses -- Health aspects -- Analysis, Health
Abstract

2023 MAR 17 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- According to news reporting based on a preprint abstract, our journalists obtained the [...]

Published
2023

37. Analysis of the SARS-CoV-2 spike protein revealed that blocked receptor-binding domain antigenicity decreases the production of neutralizing antibodies in vivo

Subjects
Protein binding -- Health aspects -- Analysis, Viral antibodies -- Health aspects -- Analysis, Vaccines -- Health aspects -- Analysis, Antibodies -- Health aspects -- Analysis, Health
Abstract

2023 MAR 15 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- According to news reporting based on a preprint abstract, our journalists obtained the following quote [...]

Published
2023

38. Delivery Of Medical Devices (multiple Hematomatic Infections Of Antigens|antibodies Of The Ivd, Set, Immunosorbent Analysis (elisa) For 2023)

Subjects
Medical equipment -- Health aspects -- Analysis, Viral antibodies -- Health aspects -- Analysis, Antigens -- Analysis -- Health aspects, Infection -- Health aspects -- Analysis, Physiological apparatus -- Health aspects -- Analysis, Antibodies -- Health aspects -- Analysis, Business, international
Abstract

Tenders are invited for delivery of medical devices (multiple hematomatic infections of antigens/antibodies of the ivd, set, immunosorbent analysis (elisa) for 2023) Major organization : STATE ORDER COMMITTEE OF THE [...]

Published
2022

39. Spear Bio's NAB-Sure Test Kit Aids Analysis of COVID-19 Immune Response

Subjects
Viral antibodies -- Health aspects -- Analysis, Enzyme-linked immunosorbent assay -- Health aspects -- Analysis, Vaccines -- Health aspects -- Analysis, Antibodies -- Health aspects -- Analysis, General interest, News, opinion and commentary
Abstract

WOBURN: Spear Bio has issued the following news release: Pharmaceutical drug developers and healthcare researchers need innovative tools to understand COVID-19 immune response and validate vaccines and therapeutics critical to [...]

Published
2022

40. Spear Bio's NAB-Sure(TM) Test Kit Aids Analysis of COVID-19 Immune Response

Subjects
Viral antibodies -- Health aspects -- Analysis, Enzyme-linked immunosorbent assay -- Health aspects -- Analysis, Antibodies -- Health aspects -- Analysis, Business, News, opinion and commentary
Abstract

New Neutralizing Antibody Test Kit has High Sensitivity and Ability to Analyze Micro-Samples WOBURN, Mass., Aug. 22, 2022 /PRNewswire/ -- Pharmaceutical drug developers and healthcare researchers need innovative tools to [...]

Published
2022

42. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants

Subjects
Viral antibodies -- Health aspects -- Analysis, Antibodies -- Health aspects -- Analysis, Business, Health, Health care industry
Abstract

2022 DEC 18 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- According to news reporting based on a preprint abstract, our [...]

Published
2022

43. Study reveals potential cause of widespread organ inflammation in COVID-19

Subjects
Inflammation -- Analysis -- Health aspects, Viral antibodies -- Health aspects -- Analysis, Antibodies -- Health aspects -- Analysis, General interest, News, opinion and commentary
Abstract

Byline: BRIAN P. DUNLEAVY COVID-19 causes widespread inflammation in the bodies of those infected by killing off two types of immune cells found in the blood and lungs, according to [...]

Published
2022

44. Negative Evidence for Antibody-Dependent Enhancement of COVID-19 Discussed in Journal of American Physicians and Surgeons

Subjects
Vaccination -- Health aspects -- Analysis, Viral antibodies -- Health aspects -- Analysis, Vaccines -- Health aspects -- Analysis, Surgeons -- Health aspects -- Analysis, Antibodies -- Health aspects -- Analysis, Banking, finance and accounting industries, Business
Abstract

TUCSON, Mar 28, 2022 (GLOBE NEWSWIRE via COMTEX) -- Antibody-dependent enhancement (ADE) is the puzzling paradox in which virus-specific antibodies, instead of neutralizing the virus, enhance its entry to cells [...]

Published
2022

45. The Longitudinal Analysis of Convergent Antibody VDJ Regions in SARS-CoV-2 Positive Patients Using RNA-seq

Subjects
Viral antigens -- Analysis -- Health aspects, Viral antibodies -- Health aspects -- Analysis, RNA -- Health aspects -- Analysis, Severe acute respiratory syndrome -- Analysis -- Health aspects, Antibodies -- Health aspects -- Analysis, Coronaviruses -- Health aspects -- Analysis, Health
Abstract

2022 NOV 21 (NewsRx) -- By a News Reporter-Staff News Editor at Respiratory Therapeutics Week -- According to news reporting based on a preprint abstract, our journalists obtained the following [...]

Published
2022

46. New COVID-19 Study Findings Recently Were Reported by Researchers at Public Health Laboratory (Comparison of Sars-cov-2 Spike Antibody Quantitative Titer Reporting Using the World Health Organization International Standard Units By Four ...)

Subjects
Vaccination -- Health aspects -- Analysis, Viral antibodies -- Health aspects -- Analysis, Ethylenediaminetetraacetic acid -- Standards, Public health -- Analysis -- Health aspects, Vaccines -- Standards, Antibodies -- Health aspects -- Analysis, Coronaviruses -- Health aspects -- Analysis, Health, World Health Organization -- Standards
Abstract

2022 NOV 9 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Investigators publish new report on Coronavirus - COVID-19. According to news reporting from Edmonton, Canada, [...]

Published
2022

47. Study shows that COVID-19 booster jabs provide better immunity against SARS-CoV-2 variants in elderly Singaporeans

Subjects
Pfizer Inc., Aged -- Analysis -- Health aspects, Communicable diseases -- Health aspects -- Analysis, Vaccination -- Health aspects -- Analysis, T cells -- Analysis -- Health aspects, Viral antibodies -- Health aspects -- Analysis, Vaccines -- Health aspects -- Analysis, Antibodies -- Health aspects -- Analysis, Pharmaceutical industry -- Health aspects -- Analysis, Health
Abstract

2022 OCT 26 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Elderly Singaporeans who are above 60 years old develop weaker vaccine-acquired immunity against COVID-19 upon [...]

Published
2022

48. Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against Omicron

Subjects
Antigenic determinants -- Analysis -- Health aspects, Viral antibodies -- Health aspects -- Analysis, Antibodies -- Health aspects -- Analysis, Business, Health, Health care industry
Abstract

2022 OCT 16 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- According to news reporting based on a preprint abstract, our [...]

Published
2022

49. Affinity-matured homotypic interactions induce spectrum of PfCSP-antibody structures that influence protection from malaria infection

Subjects
Malaria vaccine -- Health aspects -- Analysis, Viral antibodies -- Health aspects -- Analysis, Malaria -- Health aspects -- Analysis, Vaccines -- Health aspects -- Analysis, Antibodies -- Health aspects -- Analysis, Health
Abstract

2022 OCT 5 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- According to news reporting based on a preprint abstract, our journalists obtained the following quote [...]

Published
2022

50. Spear Bio's NAB-Sure[TM] Test Kit Aids Analysis of COVID-19 Immune Response

Subjects
Viral antibodies -- Health aspects -- Analysis, Enzyme-linked immunosorbent assay -- Health aspects -- Analysis, Vaccines -- Health aspects -- Analysis, Antibodies -- Health aspects -- Analysis, Health
Abstract

2022 SEP 7 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Pharmaceutical drug developers and healthcare researchers need innovative tools to understand COVID-19 immune response and [...]

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results